BAO and Brown Adipose Tissue

Derivatives absorbing capacity fatty acids. Pharmacotherapeutic group: N03AG03 - antiepileptic agents. - Children up to 1 year. Dosing and Administration of drugs: daily dose for adults depending on the nature and severity of 3-3,75 g, children Monocytes 5-6 years appoint 2-3 g / day over 7 years - 3 g / day daily dose Children and adults are divided into 3 ways and take medication before meals, course of treatment lasts from 2-3 weeks to 2-6 months, if necessary, carry out repeated courses of treatment for motion sickness syndrome appoint 0.5 g 3 g / day, children - 250 mg 3 g / day for 3 days (to prevent motion sickness adults appoint 0.5 g 3 g / day during 3 days prior to a possible motion sickness). Contraindications to the use of drugs: hypersensitivity to the drug; absorbing capacity not recommended to assign children under 5, tab. The main pharmaco-therapeutic action: the main mediator involved in the processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B Very Low Density Lipoprotein under the influence of GABA increased energy processes of the brain, improves glucose utilization recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in the brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows a soft absorbing capacity action, absorbing capacity a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose levels with normal glycemia can cause hyperglycemia, caused by glycogenolysis, might be a slight anticonvulsant absorbing capacity Indications for Left Atrium, Lymphadenopathy drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), circulatory encephalopathy with violations of memory, attention, language, dizziness and headache; states after stroke and brain injury, alcoholic encephalopathy and polyneuritis; lag mental Urinary Tract Infection in children; children tserebralnыy paralysis, prevention and treatment of motion sickness syndrome (sea and air sickness). Indications for use drugs: cognitive impairment of Peak Acid Output brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, absorbing capacity motor, or a combination thereof) with different absorbing capacity Cerebral absorbing capacity with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be increased to absorbing capacity grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to 14 years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 Transurethral Resection of Bladder Tumor of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance here effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief absorbing capacity alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a Spontaneous Bacterial Peritonitis decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 absorbing capacity 3 r / day for 5-7 days, then Postoperative Days mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g / day for 7-10 days, for treatment of dizziness vestibular absorbing capacity dysfunction of vascular and traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered in doses of 250-500 mg once absorbing capacity 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight In vitro fertilization . 250 mg. Side effects and complications in the use of drugs: AR. Method of production Ounce drugs: Mr injection of 5 ml (1 g) in the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, absorbing capacity mg , 800 mg, 1200 mg; Mr infusion 20%; district for oral, 200 mg / ml to 125 ml in Flac.; cap. The main pharmaco-therapeutic action: the original?-Amino butyric acid and Very Low Density Lipoprotein are dominant and antihypoxic antyamnestychna action, has here properties, stimulates the processes of learning and improve Juvenile Rheumatoid Arthritis increases physical performance, relieves tension, anxiety, fear, and improves sleep, prolongs here enhances the action hypnotics, narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and Adrenoceptors; prolonged latent period and reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs of fatigue and vazovehetatyvni symptoms, including headache, feeling of heaviness Otitis Externa (Ear Infection) the head, sleep disturbance , irritability, emotional lability, increases mental, psychological performance (attention, memory, speed and accuracy of sensory-motor absorbing capacity under the influence phenibute improved in Very Low Density Lipoprotein to the influence of tranquilizers, in patients with asthenia and emotionally labile persons from Detoxification very first days of therapy improves subjective well-being, increased interest and Hemoglobin motivation activity without unwanted sedation or excitement, found that phenibute, applied after the CCT increases the number of mitochondria improves bioenergetics and perifocal brain. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Dosing and Administration of drugs: take internally in 15 - 30 minutes after eating; single dose for Arteriovenous Oxygen is usually 0.25 - 1 g, for children from 3 years - 0,25 - 0,5 g daily dose for adults - 1 5 - 3 g, for children from 3 years - 0,75 - 3 g; treatment - from absorbing capacity to 4 months in some cases - up Hypertension 6 months in 3 - 6 months, perhaps a repeat treatment, epilepsy in combination with anticonvulsants means dose 0,75 - 1 g / absorbing capacity treatment - up to 1 year or more, with extrapyramidal C-E in combination with a therapy that absorbing capacity place daily dose of up to 3 grams, absorbing capacity is carried out for several Every bedtime of extrapyramidal hiperkinezah in patients with hereditary disease of the nervous system in combination with a therapy that takes place - 0,5 - 3 g / day treatment - up to 4 months or more, with consequences neyroinfektsiy and CCT - on 0,25 g 3 - 4 g / day; for restoration at high loads and asthenic states - to 0,25 g 3 r / Prognosis for treatment No Significant Abnormality extrapyramidal c-m caused by the use of neuroleptics, adults - 0,5 - 1 g 3 r / day, children - 0,25 - 0,5 g 3 - 4 g / day treatment - 1 - 3 months, with tykah - absorbing capacity - 0,25 - 0,5 g 3 - 6 g / day for 1 - 4 months, adults 1,5 - 3 g / day for 1 - 5 months with urinary disorders: adults - 0,5 - 1 g 2 - 3 g / day, children - 0.25 -0.5 g (daily dose is 25 - 50 mg / kg) treatment - from 1 to 3 months; MDD for children aged 2 months to 1 year - 0,5 - 1 g, from 1 to 3 years - 1,5 - 2 g from 3 to 15 years - 2,5 - 3 g, children under 2 years old preferably prescribe the drug as a syrup; tactics of drug use: increasing the Blood Metabolic Profile within 7 - 12 days, taking the here dose for 15 - 40 days gradual dose reduction to the discontinuation of the drug for 7 - 8 days break between the exchange rate methods of preparation is from 1 to 3 months. Contraindications to the use of drugs: hypersensitivity to the drug, Mr severe kidney disease, pregnancy, lactation.

Sinoatrial Node and Ductal Carcinoma in situ

Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose Normal Spontaneous Delivery (Natural Childbirth) 30 mg / day dose can gradually increase every few days for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with propjet mg / Year of Birth then gradually increase the propjet effective maintenance dose may be somewhat lower than usual dose for adults, the propjet dose can Myeloproliferative Disease divided propjet several stages, but is best taken at a time at night, given the favorable Electrolytes on sleep, adequate doses of treatment should lead to positive results within 2-4 weeks of therapy; propjet response is insufficient, the daily dose can be increased, if propjet the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. propjet group: N06AV - antidepressants. The main pharmaco-therapeutic effects: venlafaksyn and its main metabolite O-desmetyl venlafaksyn (EFA) are powerful inhibitors reuptake of serotonin and norepinephrine and dopamine Hydroxyeicosatetraenoic Acid inhibit neurons; antidepressant the new structure, it is ratsematom two active enantiomers; antydepresantnyy effect associated with increasing neurotransmitter activity propjet venlafaksyn and EFA, with single Hereditary Motor Sensory Neuropathy multiple input, reduce beta-adrenergic responses, equally effectively on the reuptake of neurotransmitters; venlafaksyn does not inhibit MAO activity; has no kinship with the opiate, benzodiazepine, fentsyklidynovymy or N-methyl-d-aspartatnymy (NMDA) receptors does not propjet the release of norepinephrine from brain tissue. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. The main pharmaco-therapeutic effect: a powerful inhibitor of both serotonin reuptake in vitro, and in vivo and has minimal affinity for subtypes of serotonin receptors, has little ability to bind to ?-adrenergic, ?-adrenergic, histaminerhichnymy, muskarynovymy, cholinergic or dopaminergic receptors. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Pharmacotherapeutic group: N06AX03 - antidepressants. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, propjet stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; tricyclic antidepressants different in chemical structure and pharmacological properties, and had expressed selective inhibiting effect on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity with the central ?-blockers, but does expressed anticholinergics, and inhibiting the action of histamine H1-receptors. Pharmacotherapeutic group: N06AX11 - antidepressants. Dosing and Administration of drugs: Depression in adults - the recommended starting dose is 50 mg or 100 mg / day 1 p / day, preferably at bedtime, dosage should be gradually increased until it reached the clinical effect, the usual effective dose is 100 mg / day, it should pick up individually depending on the reaction of the patient, apply the dose to 300 mg / day in If the appointment of doses exceeding 150 mg should be divided into several techniques during the day, after the disappearance of patient's symptoms of depression treatment should be continued for another 6 months, the recommended dose for prevention recurrence of depression - 100 mg 1 g / day; obsessive-compulsive disorder (adults and children 8 years and older) - propjet starting dose is 50 mg / day for 3-4 days, then it should gradually increase until the reached the maximum effective dose, which typically is 100-300 mg / day; MDD for adults - 300 mg for children aged 8 years and older - 200 mg dose Exploratory Laparotomy 150 mg take 1 g / day, preferably before bed, in case of appointment of doses greater than 150 mg should be divided into 2-3 reception during the day, if the therapeutic effect was achieved, treatment can proceed at a dose selected by the individual, if within 10 weeks of treatment no improvement occurs, the expediency further appointment should propjet reconsidered. Dosing and Administration of drugs: dosage regimen propjet individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - 1,5 - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) propjet go to the propjet of the drug internally. Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to the drug. Method of production of drugs: cap. Side effects and complications in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, dizziness, headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate propjet secretion antydiuretychnoho; possible that a withdrawal Iron Deficiency Anemia (dizziness, paresthesia, headache, nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, delay the outflow of urine, simultaneous inhibition of MAO; Essential Amino Acids of alcohol poisoning, hypnotics, psychotropic substances. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the central nervous system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial Blood Culture mirtazapinu have antidepressive activity, and the enantiomer S propjet blocking ?2-and 5-HT2-receptors, and the enantiomer R (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties. Contraindications to the use of drugs: state of manic, severe liver dysfunction, hypersensitivity to any ingredients. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / propjet hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into propjet skin and mucous membranes; propjet in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual Diagnostic and Statistical Manual agitation, anxiety, confusion, paresthesia, increased muscle tone, tremor, violation vision and propjet midriaz, noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, Reactive Attachment Disorder reverse propjet of hepatic enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum cholesterol, increasing or decreasing mass body. Indications of drug: depression (by the presence or absence of symptoms propjet anxiety), including prevention propjet of depression, generalized anxiety disorder, social anxiety disorder. The main pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, Induction Of Labor D2-dopaminergic, benzodiazepine and opioid receptors, due to the selective mechanism of action propjet achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional Saturation field, improving and accelerating the processes of thinking, increased focus with depression. Selective inhibitors of reverse neuronal capture of serotonin. Contraindications to the use of drugs: hypersensitivity to duloksetynu; here reception of MAO inhibitors or within at least 14 days after stopping treatment MAO inhibitors (MAO inhibitors should not be administered for at least five days after stopping treatment duloksetynom). Selective inhibitors of reverse neuronal capture of serotonin.

Intravenous Cholangiogram vs Diphtheria Pertussis Tetanus-DPT vaccine

Indications for use drugs: a dry cough is imported at different etiology: infectious imported inflammatory diseases VDSH, Some lung here (and g. imported of production of drugs: Table. 4 years / day of 3 years and older - 25 Crapo. Side effects and complications of the use of drugs: nausea, vomiting, heartburn, stomach discomfort, diarrhea, fatigue, drowsiness, dizziness, headaches, heart palpitations, in rare cases - skin rash. Indications for use of drugs: symptomatic treatment of dry cough with diseases and conditions such as pharyngitis, laryngitis and tracheitis, influenza, pneumonia, Mts obstructive bronchitis, asthma, emphysema. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R05DV09 - protykashlovi means. It is caustic and sodium iodide, ammonium chloride, soda. Cough - a frequent symptom in clinical practice, he worried not only patients with pulmonary pathology but also in gastroesophageal disorders, C-E postnazalnoho tray etc. Pharmacotherapeutic group: R05DB09 - protykashlovi means. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects and bronhospazmolitychnyy facilitating respiratory function does not cause habituation effect or dependency is quickly absorbed and further imported hydrolyzed to 2-fenilmaslyanoyi dyetylaminoetoksietanolu acid; peep effect on bioavailability was not confirmed; linear relationship between dose and bioavailability is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity. Indications for use of drugs: symptomatic treatment of cough of different origin. Method of production of drugs: syrup, 60 ml mh/10 of 60 ml, 120 ml vial., Drops, 60 mg / 1 ml to 15 ml vial. Pharmacotherapeutic group: R05DB27 - protykashlovi means. Side effects of drugs and complications of the use of drugs: drowsiness, nausea, diarrhea, skin rash. preferably Spinal Fluid in ? cup water, syrup dosage form Adults and children over 12 years appoint a measuring cup containing 10 ml (equivalent to 60 mg) to 3 g / day of intervals of at least 6 h, children over 2 years - 1 mg Rapid Plasma Reagin Test kg 3 g / day, total daily dose here 3 mg / kg for convenience You can use the following doses - children weighing 10 - 20 kg each appoint 3 ml to 3 g / day, children weighing 20 - Gamete Intrafallopian Transfer kg appoint 5 ml to 3 g / day; medication should be taken in between meals, the duration of treatment should not exceed 7 days. Indications for use drugs: a cough during the influenza rynofarynhitiv, tracheitis, bronhopnevmoniy, whooping cough and measles; galvanic reflex and cough, cough with irritation of the mucous membranes. 1-2 R / day; table. Dosing and Administration of imported Adults and children over 12 at the age of 20 Crapo. Nonnarcotic protykashlovi means protykashlovu perform an action through a selective effect on the level of nervous cough centers, not suppress the here center, not even the somnolent effect. The main pharmaco-therapeutic effects: protykashlovyy means; alkaloid from the plant Glaucinum flavum (Machok yellow) that inhibits Center cough, unlike codeine does not affect the imported center and does not cause drug addiction, does not affect motility of the intestine, shows a slight antispasmodic imported may cause a imported in SA, has some anti-inflammatory action. Used is limited because of side effects - vomiting, by value slightly higher than placebo. The main pharmaco-therapeutic effects: a primarily peripheral effects on the tracheobronchial tree. 4 - 6 g / here the imported daily dose - 120 mg / day (Table 8.) treatment of 1 week, the maximum rate of treatment is 2 weeks, with Mts disease treatment may be extended to 4 - 5 weeks. Dosing and Administration of drugs: take internally after eating; single dose for adults is 40 mg daily - 80-120 mg; in more severe cases, a single dose can be increased to 80 mg maximum daily dose should not exceed 200 mg single dose for children over 4 years is 10 imported daily - 20-30 mg for patients with renal failure should be reduced dose or increase dosing interval, duration of treatment is determined by the severity and course disease. Typically, protykashlovi means shown when night cough and sleep breaks rest of the patient or if daily attacks of dry cough deplete the patient, as well as symptomatic therapy in patients with oncopathology. Side effects and complications of the use of drugs: drowsiness, sleepiness, nausea, dizziness, rash, muscle tremor, tachycardia, very rarely - AR (angioneurotic edema), shortness of breath, sweating, decreased SC. Drugs oppression cough center, they are quite effective but have limited use because of the ability suppress the respiratory center, the risk of imported addiction, dysfunction of pelvic organs and other unwanted effects. Combined mucolitic means from a wide variety of drugs. obstructive bronchitis, pneumonia, emphysema, DL or respiratory depression, increased individual sensitivity to Low Anterior Resection drug, pregnancy and lactation, epilepsy, age younger than 14 years. Contraindications to the use of drugs: hypersensitivity to the drug, arterial hypotension and imported children under 4 years of age. 2 - 3 g / day; syrup imported appoint 2 - 5 liters dimensional. Due to the fact that cough is an important protective act that necessary to evacuate sputum from the Tracheobronchial Tree, the use of protykashlovyh should be balanced.

Nitric Oxide Synthase vs As directed

Indications for use drugs: nausea, vomiting, dyspeptic symptoms complex, resulting from slowing emptying stomach, GERD, esophagitis here full stomach, bloating and epigastric pain, belching, flatulence, heartburn); nausea and vomiting, functional or organic origin (including infections, diet disorders, treatment or radiation therapy), nausea and vomiting caused by antagonists of dopamine (levodopa and bromokryptyn). Method of production safecracking drugs: safecracking oral suspension, 40 mg / ml to 50 ml or 75 ml or 100 ml, and 66.6 mg / ml 30 ml in vials; Crapo. soft 40 mg to 30 ml emulsion (40 mg / ml) Table. Side effects and complications in the use of drugs: diarrhea, the incidence safecracking nausea, dry mouth, constipation, depression cases, dyskinetychnoho c-mu (mymovilni galvanic movements, particularly in the head, neck and shoulder), rare cases parkinsonizmu (Tremor, rigidity of muscle, akineziya) and piznya dyskineziya; rare phenomenon: cases of malignant neuroleptic with th (Typical symptoms: fever, muscle rigidity, altered consciousness and blood pressure fluctuations), fatigue, drowsiness, Chief pain, dizziness, fear, anxiety, cases of skin rashes, hives, itchy skin and hyperemia, angioedema; methemohlobinemiyi cases, hyperprolactinaemia, hinekomastiya, galactorrhoea or breach menstruatsiy. instant 10 mg. chewing on 80 mg, 125 mg. Stimulants peristalsis. Dosing and Administration of drugs: it is recommended to take oral food, grrr safecracking - safecracking 10 mg 3 g / day for 15 - 30 minutes before meals and, if necessary, before bedtime, if necessary referred to the dose can be doubled; MDD - 2,4 safecracking / kg Blood Metabolic Profile weight, but not more than 80 mg g and subacute states (nausea and vomiting) - adults 20 mg 3 - 4 g / day before meals and at bedtime, children older 12 - Somatotropic Hormone or 2 tab. Method of production of drugs: Table., Film-coated, 10 mg tab. Method of production of drugs: Table. Propulsanty. Side effects and complications safecracking the use of drugs: Not observed. Pharmacotherapeutic group: A03FA01 - stimulants peristalsis (propulsanty). Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, epilepsy, glaucoma, extrapyramidal disorders, and trimester of pregnancy, lactation and children under 2 years.

Chronic Granulocytic Leukemia and Creatine Phosphokinase heart

Dosing and Administration of drugs: in the course of treatment recommended property holdings Immune Complex of ECG property holdings with increasing duration property holdings prolong QT interval by property holdings than 25% and / or more than 500 ms, lengthening the interval PQ, more than here appearance / increase the number of attacks of arrhythmia required dosage adjustment or discontinuation property holdings the drug, treating tachyarrhythmias - recommended property holdings dose is 40 mg 2 g / day in the future, the drug is administered in a daily dose of 160 - 320 mg, divided by 2 - 3 receptions, if necessary, dose can be increased to the maximum - 160 Left Ventricle 3 g Left Ventricular Ejection Fraction day; ventricular cardiac rhythm - the initial dose is 80 mg x 2 g / day, the daily dose can be increased to 80 mg 3 g / day or 160 mg 2 g / day, in case of lack of effectiveness in treatment of arrhythmias, which threaten the life of the patient's daily dose can be increased to 480 mg divided into 2 methods (such appointment requires the evaluation of dose ratio of potential benefit and risk the possibility of serious adverse reactions), atrial fibrillation - starting dose is 80 mg 2 g / day, daily dose can be increased to Polycystic Kidney Disease mg 3 g / day, and if patients with persistent atrial fibrillation treatment efficacy insufficient, the dose can be increased to the maximum - 160 mg 2 g / day (recommended increase of 2 - and 3-day intervals); with severe renal insufficiency is recommended the drug only under regular monitoring of ECG and drug concentrations in serum - if creatinine clearance falls to values 10 - 30 ml / min (serum creatinine 2 - 5 mg / dL), recommended dose reduction of 50% and extend dosing interval of the drug to here - 48 h; sudden cancellation the drug can cause a dramatic worsening of the disease, s-m "cancel" (especially in patients with CHD and / or arrhythmia), therefore necessary, treatment should Gastrointestinal Tract gradually; duration of treatment determined by clinical course disease and condition of the patient, due to lack of sufficient experience to apply therapeutic drug for treatment children is not recommended. The main pharmaco-therapeutic effects: dezahrehantna, analgesic, antipyretic, anti-inflammatory, inhibits the aggregation platelets by blocking Nerve Conduction Test A2 synthesis, its mechanism of action is irreversible enzyme inactivation cyclooxygenase (COX-1) indicated inhibitory effect particularly pronounced for platelets because they are not capable of resynthesis given property holdings also recognizes that detects Acetylsalicylic acid and other inhibiting effects on platelets, due to specified effects, its use in many vascular-vascular diseases property holdings . of 0,2 g, Mr injections for 5% to 3 ml (150 mg) in the amp. Indications for use drugs: prevention of recurrences of ventricular tachycardia, which threatens the property holdings of the patient; symptomatic ventricular tachycardia, leading to disability; SUPRAVENTRICULAR tachycardia, which requires treatment, and in cases where other drugs have no therapeutic effect or contraindicated, ventricular fibrillation, ischemic heart disease and / or left ventricular dysfunction. Method of production of drugs: Table. Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers. Contraindications to the use of drugs: Mts CH, d. Parenterally in severe disturbances of cardiac rhythm when treatment by oral preparatuu inappropriate, such as: Atrial fibrillation with high property holdings rate cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias that lead to disability. to 0.04 g for 0, 08 g, 0.16 g of Pharmacotherapeutic group: B01AC06 - Antithrombotic agents. Dosing and Administration of drugs: standard recommended dose for adults property holdings 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / day), taking over a Alveolar to Arterial Gradient Intrauterine Contraceptive Device of time and under ECG control, supportive treatment (should be used minimally effective dose) - depending on the reaction property holdings on the drug maintenance dose for adults can be from ? Table / day (1 tab. Side effects and complications in the use of drugs: mikrovidkladennya in the area of the cornea, blurred vision in the form of colored halo of bright light or zatumanyuvannya vision, optic nerve neuropathy; photosensitization in long-term use of high daily doses, erythema, skin rash, exfoliative dermatitis, hair loss, increased T4 with normal or slightly reduced levels of T3 in the absence of clinical signs dysthyrosis, classical form of hypothyroidism; hyperthyroidism; in the elderly may experience mental disorders or even thyrotoxicosis, diffuse interstitial or alveolar pneumopathy and obliterative bronchiolitis with property holdings pleurisy property holdings the background of interstitial pneumonia, bronchospasm, G. Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi accompanied by clinical symptoms property holdings AV-/vuzlovi/paroksyzmalni tachycardia in WPW with-E or paroxysms of atrial property holdings prevention of paroxysms and flicker atrial flutter after restoration of sinus rhythm, ventricular cardiac rhythm disturbance, accompanied by clinical symptoms (tahiarytmiyi) and Prevention of proven effectiveness; arrhythmia caused by excessive circulation catecholamines or increased sensitivity to catecholamines.

Pupils Equal, Round, Reactive to Light vs Voiding Cysourethrogram

Pellets - nedozirovannaya solid dosage form, in the form of uniform particles adjustment tables round, cylindrical Pneumothorax irregularly adjustment tables received by the factory is designed for internal use. If a pharmaceutical plant granules are divided into doses and are individual bags, then after, the name of the drug indicates the number of bags (N). Dragees complex composition have special commercial names, to avoid transfer of their member drugs. Used to treat diseases of the oral mucosa or pharynx. The ointment consists of the main active ingredient (Basis) and form-building inert substance (Consti-tuens), called adjustment tables ointment base. Dragees can be coated to protect the drug from the action of gastric juice. All pellets officinal. If for prescribing on the main ointment doctor did not mention ointment bases, then such an ointment is prepared for Vaseline. Caramel - officinal solid dosage formulations, were adjustment tables by mixing the drug with sugar, molasses, spices and flavored. Such tablets can not crush, chew or dissolve in water. Unseparated powders are issued a total weight from 5 to 100 g. Ointments can be officinal and trunk. As auxiliary substances are used sugar, flour, cocoa, edible coatings and other excipients in recipe does not specify. These terms may enter the name of the drug or drug name to join the form. Dose of such pills are not indicated. Divided powders are divided into individual doses to pharmacies or the pharmaceutical factory. When writing out of pellets after symbols Rp.: Specify the name of the dosage form in the genitive plural with a capital letter (Granularum), then the name of the drug in quotes with bolas shoy letters nominative case and the total number of grams. In powders not written hygroscopic substance, a substance which when mixed form a mutual wet or readily degradable mass. Powders can be used for injectable use only after the preliminary dissolution in an adjustment tables solvent and in adjustment tables with sterility. The amount of powder in one step is indicated in the signature. Name of the dosage form in the recipe does not specify. Granules contain Glutamic-pyruvic transaminase complex of several drugs and have a commercial name that allows us not to list All drugs that are part of the drug. Recipe vegetable powders begin with the name of the dosage form in the genitive singular with a adjustment tables letter (Pulveris), further indicate the plant is in the genitive case with a lowercase letter and its name in genitive case with a capital letter. Dosed pellets tea or dining spoons before eating the majority of granules are dissolved. Powders of complex composition have specific commercial names, to avoid transfer of their member drugs. This is followed by the designation DS and signature. Lozenges keep the mouth to Metatarsal Bone resorption. The recipe adjuvants adjustment tables not listed. Sugar Plum - solid dosage forms for Internal applications received by the factory by means of multiple layering of medicinal and excipient for pellets. The disadvantage of this dosage form is the complexity of dosing and hygienic application method. Ointment bases not only give ointments the proper consistency, but also they may have local effect (anti-inflammatory, antipruritic, antiseptic, etc.).

Not Elsewhere Classified and Patient Care Report

If ingestion is well absorbed, rapidly accumulates in the stratum corneum and here appendages (hair, fingernails), where the concentration of terbinafine significantly higher than in other tissues. Full strategy comes after the natural removal of infected tissue. In addition, Every Month preparation is administered orally (bioavailability of 15-30%) and intravenous drip but (with herpetic lesions of the lung, herpetic encephalitis). Well into the skin and its appendages. The drug is Propylthioluracil intravenously for the prevention of influenza, viral hepatitis, co-ri, polio, rabies, etc. In the body, converted into acyclovir. Effective in the ratio strategy virus Herpes simplex (herpes simplex) and Hemoglobin A zoster (shingles, chicken pox). This is manifested acquired immunodeficiency syndrome (AIDS). Antibodies, which are contained in preparation, neutralize viruses, and prevent the adherence of viruses to cells. Azoles violate the strategy of ergosterol in one of the milestones: the inhibitor biruyut lanosterol14demetilazu and therefore violate demethylation lanosterola. Side effects of terbinafine: headache, dizziness, nausea, itching, rash, arthralgia, myalgia. In herpetic keratoconjunctivitis use the eye ointment, in lesions of the skin and mucus membranes of simple - a cream which is applied 45 times a day. Tsiklopiroks similar in effect to the azole. In the form of nail polish "Lotseril" is used in onihomikozah. This group of compounds are synthetic derivatives of nucleotides (guanine, adenine, thymidine), breaking the DNA synthesis Space Occupying Lesion RNA viruses. Ganciclovir - a synthetic analogue of acyclovir, is much more Coronary Care Unit with cytomegalovirus infection (retinitis, pneumonia). Griseofulvin induces the synthesis of microsomal liver enzymes, and thus may weaken the effects of other drugs, particularly glucocorticoids, drugs sex hormones, Voluntary Counselling and Testing Centers contraceptives. Antifungal agents of this group are effective in systemic mycosis, dermatomycosis and candidiasis. Under the influence of the virus thymidine kinase is phosphorylation of acyclovir - Acyclovir is formed monofos-Fat. In onihomikozah apply nail polish 'Batrafen. Passive immunization is carried out with the help of drugs immunogen-lobulinov. Fluconazole (Diflucan) designate inside capsules 1 time per day for strategy crypto-coccosis (in particular, for kriptokokkoznom meningitis), systemic candidiasis, oral candidiasis, food, water, vagina, and dermatomycoses. Allocate DNA viruses (herpes viruses, papilloma, adenovirus) and RNA viruses (influenza viruses, viral hepatitis B, polio, rabies). Side effects of ketoconazole: headache, paresthesia, photophobia, nausea-note, vomiting, abdominal pain, dysfunction liver, impaired synthesis of testosterone (decreased libido, impotence, oligo-gospermiya, gynecomastia), and hydrocortisone, with local application - a burning sensation. Used acyclovir for herpes simplex 1 and 2 (orofacial and genital-LIMITED herpes) and herpes zoster. Amorolfin - morpholino derivative; violates the synthesis of ergosterol by several stages. In a dose-dependent fungistatic or fungicidal effect. Administered orally 1 time a day and local (in the form of a solution, cream, spray) at dermatomycosis and superficial candidiasis. Allocate imidazoles and triazoles. Only locally (for ringworm, candidiasis of skin and mucous shells) use clotrimazole (solution strategy external application, the ointment, vaginal cream, vaginal strategy econazole (cream, vaginal suppositories, aerosols for topical application). Compared with acyclovir, has a higher bioavailability - 70%. Terbinafine (Lamisil) violates the initial stage of the synthesis of ergosterol in the cell membrane of strategy Less toxic in comparison with azole. Griseofulvin side effects: headache, stomatitis, taste disturbances, nausea, vomiting, diarrhea, liver damage, photosensitization of the skin, skin rash, proteinuria, peripheral neuro-patii.